VSMC–NFATc3 deletion reduced thoracic AAD (TAAD) and abdominal aortic aneurysm (AAA) progression in mice, contrary to VSMC–NFATc3 overexpression. This evidence concerns the gene NFATC3 and abdominal aortic aneurysm.